Nine months ago we did not have parts of Keystone Nano and Dr. Mark Kester, or our shares (DTC-TA screw up) or the new ticker, or the website, or the recently published R&D papers of Dr. Mark Kester or Edward Mathias listed on the Website, or Larry Kubin.
It was barely 10 weeks ago that the Keystone Nano shares for parts of Keystone were bought and NDTP shares issued.
This kind of birth requires a calendar based 10-K filing with an SEC 1-A (S-1) Super 8-K package that must include every nut and bolt and detail in an AUDITED filling. Audits like this or done in weeks, and that clock started Ticking Jan 2nd.
SEC 10-K deadlines are March 31st, and late 10-Ks by April 15th.
IMO those are the windows we should watch for the filings and uplist.
So Far they have done everything on the August 2019 shareholder letter and SEC 8-K filing.
Except the SEC 10-K/S-1/1-A filing.
There is a short window once a year for doing those. You do not do an audited 10-K in November.
Or in June, July....
Edward Mathias started a Biotech Investment venture capital firm in July last year, right after we got our NDTP shares back fro the DTC.
He raised over 100 Million dollars in days.
Coincidence???
Mark Kester at the Univ of Virginia started Covid19 R&D with his Ceramides he already reached a phase III cancer trial with.
What are the odds his ceramides could used to stop cells from replicating Covid19 virus cells?
My reading of his research suggests it has some interesting possibilities. And one Univ of Virginia News Bite Bivins found says Mark Kester and his team started researching the use of his Ceramides in July last year for possible use to treat Covid19.
Did/will he succeed? Maybe.
Will NDTP be involved?
Maybe.
But we know Mark Kester and part of his Keystone Nano firm must be part of NDTP now. Nothing else would make any sense.
We Know NDTP has the CCA, LLC BBB-crossing Nano Delivery Technology.
Mark Kester's Ceramides never mentioned Brain Cancer.
Just several other types of cancers and FDA trials.
Put the two techs in NDTP, and it is no leap of faith to see they may thinking of targeting brain cancer down the road, and not just TBI-brain injury.
Much has changed in those 404 days.
My only regret is not having cash buy to 10000 more shares of NDTP
News 
Market Data 
Discover 
AI
